FDA Urges Drug Manufacturers to Develop Risk Management Plans to Promote a Stronger, Resilient Drug Supply Chain
WASHINGTON, D.C. — Patrizia Cavazzoni, M.D., Director for the Center for Drug Evaluation and Research, recently released the following statement:
FDA Urges Drug Manufacturers to Develop Risk Management Plans to Promote a Stronger, Resilient Drug Supply Chain Read More